SetPoint Medical Engages in Key Health Conference for Autoimmune Disease Care Innovations

SetPoint Medical to Present at the Bank of America Health Care Conference

SetPoint Medical, a leader in medical technology dedicated to enhancing treatment options for chronic autoimmune diseases, is set to participate in the upcoming Bank of America Health Care Conference. This significant event will take place on May 13, 2026, in Las Vegas, where the company aims to demonstrate its commitment to redefining autoimmune care.

The company’s CEO, Dr. Murthy V. Simhambhatla, will present at 4:20 p.m. ET. His presentation will focus on the FDA-approved SetPoint System®, a groundbreaking solution for managing moderately to severely active rheumatoid arthritis (RA). This system represents the first neuroimmune modulation therapy available for adults facing the challenges posed by RA, a condition affecting millions worldwide.

During his talk, Dr. Simhambhatla will discuss the recent updates regarding the SetPoint System®, including its efficacy for patients who have not responded adequately to traditional biological and targeted synthetic disease-modifying antirheumatic drugs (DMARDs). The SetPoint System® is designed for patients who struggle with significant challenges related to RA, offering new hope for effective pain management and improved quality of life.

SetPoint Medical emphasizes its commitment not only to RA treatment but also to expanding the access and application of its innovative technology for other autoimmune conditions, including multiple sclerosis. By harnessing neuroimmune modulation, the company is pioneering a novel, device-based therapeutic option that activates the body’s innate anti-inflammatory pathways, aiming to restore the immunological function disrupted by these chronic diseases.

The SetPoint System® involves a sophisticated mechanism that stimulates the vagus nerve to combat inflammation, presenting a new frontier in autoimmune disease management. SetPoint Medical has witnessed promising patient outcomes from this therapy, demonstrating its potential as a first-line option for those who cannot tolerate existing treatments.

As part of their preparations for the conference, SetPoint Medical invites investors and stakeholders interested in gaining deeper insight into its technology and future direction. One-on-one meetings with the company’s management can be arranged through arrangements with representatives from Bank of America, ensuring direct engagement with the minds behind these medical innovations.

In addition to the pivotal discussions on the SetPoint System® at this important health care conference, SetPoint Medical is committed to ongoing research and development, with plans to explore the applicability of its technology across a spectrum of autoimmune conditions. The company's mission is to enhance the lives of those afflicted by chronic autoimmunity by providing cutting-edge medical solutions and fostering a stronger understanding of these complex diseases.

With its participation in the Bank of America Health Care Conference, SetPoint Medical reinforces its position as a pioneer in the medical technology landscape, dedicated to transforming the future of autoimmune disease care through innovation and compassionate patient-centered treatments. For more information on SetPoint Medical and its initiatives, please visit setpointmedical.com.

Together, let us shine new light on the journey towards better health and well-being for those living with chronic autoimmune diseases.